ATLAS / Macro Radar / Reporting / CVKD

Cadrenal Therapeutics, Inc. (CVKD) reporting calendar

Cadrenal Therapeutics, Inc. files periodic reports with the SEC as CVKD on Nasdaq. Atlas tracks 14 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
13 Jul 2026 – 3 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
14

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 39 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CVKD market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001213900-26-053074
10-K31 Dec 202531 Mar 202690 days0001213900-26-036946
10-Q30 Sep 202510 Nov 202541 days0001213900-25-107816
10-Q30 Jun 202511 Aug 202542 days0001213900-25-073885
10-Q31 Mar 20258 May 202538 days0001213900-25-040788
10-K31 Dec 202413 Mar 202572 days0001213900-25-023759
10-Q30 Sep 20247 Nov 202438 days0001213900-24-095393
10-Q30 Jun 20247 Aug 202438 days0001213900-24-066107
10-Q31 Mar 20249 May 202439 days0001213900-24-041014
10-K31 Dec 202311 Mar 202471 days0001213900-24-021133
10-Q30 Sep 20239 Nov 202340 days0001213900-23-084937
10-Q30 Jun 202310 Aug 202341 days0001213900-23-065223
10-Q31 Mar 202310 May 202340 days0001213900-23-037929
10-K31 Dec 202230 Mar 202389 days0001213900-23-024260

Source: SEC EDGAR company submissions for CIK 0001937993. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.